611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net
Medical Disorders
Basic InformationLookupsLatest News
New Hope Against Diseases Marked by Progressive Scarring of Lung TissueAHA News: What Heart and Stroke Patients Should Know About COVID-19 VaccinesCOVID Pandemic Shortened U.S. Life Expectancy by More Than a YearShorter COVID Quarantine for College Athletes a Good Idea, Study FindsWhat Happened to the Flu This Year?3 Steps Could Nearly Eliminate COVID Infections on College Campuses: StudyPharmacy Chains Ready to Supply COVID-19 Vaccines to AmericansI've Already Had COVID-19, Do I Need the Vaccine?What Will COVID-19 Look Like Years From Now?First Computer Model of Entire COVID Virus Will Aid ResearchStopping Common Heart Meds Could Be Risky for Kidney PatientsU.S. COVID Vaccine Rollout Nears 1 Million Doses Per DayJohnson & Johnson's One-Dose COVID Vaccine Promising in Early TrialLockdowns' Benefits for Air Quality Weren't as Big as Thought: StudyPeople's 'Microbiomes' Might Influence COVID-19 Severity: StudyNew Insights Into How COVID-19 Damages the BrainCollege Campuses Are COVID 'Superspreaders,' Study FindsStuck at Home, Suffering With COVID? Experts Offer Guidance on CareCOVID Daily Death Toll Sets New U.S. Record, Soars Past 4,400AHA News: Registries Could Offer Insight Into COVID-19's Impact on College Athletes' HeartsResearch Reveals Why COVID Pneumonia Is More DeadlyPandemic Is Tied to Big Rise in U.S. Heart DeathsCommon Diabetes Meds Tied to Serious COVID-19 ComplicationPlant-Based Diet Brings Better 'Microbiome,' Healthier LifeAnswering Your Qs on the New COVID VaccinesEven Mild Cases of COVID Can Leave 'Long-Haul' Illness, Study ShowsCommon Blood Pressure Meds Won't Up Risks for COVID Patients: StudySix Months Later, Most Wuhan COVID Survivors Still Have Health IssuesHealth Officials Work to Speed Up U.S. COVID Vaccine RolloutAllergists' Group Offers Guidelines on COVID-19 VaccinesFacebook Posts Big Drivers in Vaccine Resistance, Study FindsBlack Patients at Higher Risk When Type 1 Diabetes and COVID CombineBiden Says He Will Release All Vaccine Doses After Taking Office'Pandemic Fatigue' Setting in? Here's How to Stay Safe and StrongCould High Pollen Levels Trigger Pelvic Pain?Record Number of COVID Cases, Deaths Reported in U.S.COVID Survivors' Plasma Might Prevent Worsening Illness in Older Patients: StudyAHA News: Dr. Dre Recovering From a Brain Aneurysm. What Is That?Certain Antibiotics Linked With Upped Risk for Deadly Aortic AneurysmsDeath Risk Nearly Doubles When COVID Strikes People With Heart FailureMore Infectious COVID Variant Likely Widespread in the U.S., Experts SayRed Cross Issues Call for More Blood Plasma to Treat COVID PatientsPediatricians' Group Says School Is Priority, With Proper Safety MeasuresMoves, Evictions Often Trigger Harmful Breaks in Health Care: StudyAllergic Reactions to COVID Vaccines Are Rare, Resolved on Site: CDCSurvey Shows Mental Woes Spiked in U.S. Pandemic's First MonthsYour 'To-Do' List as You Await a COVID VaccineSome Americans Can't Access Telemedicine, Study ShowsU.S. COVID Hospitalizations Reach Record High as California Hospitals Run Out of OxygenVaccine Rollout Could Have Americans Back to Normalcy by Summer, Expert Says
Questions and AnswersLinksBook Reviews
Related Topics

Men's Health
Women's Health

Almost 47 Million Americans Already Infected With Coronavirus by Nov. 15: Study

HealthDay News
by By Ernie Mundell HealthDay Reporter
Updated: Jan 5th 2021

new article illustration

TUESDAY, Jan. 5, 2021 (HealthDay News) -- By Nov. 15 of last year, roughly 47 million Americans -- about 14.5% of the U.S. population -- had already been infected with the new coronavirus, a new study finds.

That's much higher than the close to 11 million known U.S. cases of infection that were recorded by that date, the researchers said, because reported cases "do not represent the full SARS-CoV-2 disease burden."

"Case reports are dependent on patients seeking health care," among other factors, and at least 40% of all infections are thought to be asymptomatic, according to a team led by Dr. Frederick Angulo. He works in medical development and scientific/clinical affairs at Pfizer Vaccines, which has an approved COVID-19 vaccine already in distribution in the United States.

It's believed that everyone who becomes infected with the new coronavirus will develop some form of immunity. And if enough of the population (about 70%) were to gain immunity -- either through infection or vaccination -- so-called "herd immunity" would set in, thwarting the virus' ability to spread further.

But the numbers for Nov. 15, 2020 show that herd immunity is still far away, the research team said.

"Findings of this study suggest that although more than 14% of the U.S. population was infected with SARS-CoV-2 by mid-November, a substantial gap remains before herd immunity can be reached," they reported Jan. 5 in JAMA Network Open.

The Nov. 15 numbers were based on a total U.S. count of recorded cases on that date of 10,846,373.

Infection rates have exploded across the United States since then, and according to a tally kept daily by The New York Times, more than 20.8 million verified cases have been recorded as of Tuesday.

Even so, Americans remain far away from herd immunity, one expert said, so the rollout of a nationwide vaccination campaign remains imperative.

"While it has always been the case that a major underestimate of the true disease burden with COVID-19 has been present, most parts of the country have not reached herd immunity," said Dr. Amesh Adalja, an infectious disease expert and senior scholar at the Johns Hopkins Center for Health Security, in Baltimore.

"This underscores the need for vaccination uptake to be optimal to put this pandemic behind us," Adalja said.

In their study, Angulo's group analyzed data from four "seroprevalence" (blood test) surveys conducted by the U.S. Centers for Disease Control and Prevention in April, May, June, July and August. These surveys were conducted in 10 states (California, Connecticut, Florida, Louisiana, Minnesota, Missouri, New York, Pennsylvania, Utah and Washington). A fifth CDC survey was conducted in 47 states nationwide.

All of that data helped the researchers estimate the level of "under-reporting" of coronavirus infections -- the gap between the number of people recorded as having COVID-19 and the larger "true" number of cases, reported and unreported.

Angulo's team used those calculations to come up with an estimated number of 46,910,006 cases of SARS-CoV-2 infection having occurred among Americans by Nov. 15, 2020.

The researchers stressed that the COVID-19 pandemic is not a static phenomenon, so these calculations "will change over time as the proportion of persons with infection tested, diagnosed and reported changes." Their calculations may, in fact, be "conservative," the team said.

The introduction of an immunization campaign could change the numbers greatly, as well, so additional surveys are needed "to monitor the pandemic, including after the development of safe and efficacious vaccines," Angulo and colleagues concluded.

More information

Find out more about the unfolding pandemic at the U.S. Centers for Disease Control and Prevention.

SOURCES: Amesh Adalja, MD, senior scholar, Johns Hopkins Center for Health Security, Baltimore; JAMA Network Open, Jan. 5, 2021, online